Quick jump to page content
Main Navigation
Main Content
Sidebar
Register
Login
Toggle navigation
Home
About
About the Journal
Submissions
Editorial Team
Privacy Statement
Contact
Current
Archives
Submission
Dermsquared
Search
Search
Search articles for
Advanced filters
Published After
2017
2018
2019
2020
2021
2022
2023
2024
January
February
March
April
May
June
July
August
September
October
November
December
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Published Before
2017
2018
2019
2020
2021
2022
2023
2024
January
February
March
April
May
June
July
August
September
October
November
December
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
By Author
Search Results
Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 weeks: Subgroup Analyses from the Effisayil 2 Trial
Richard Warren, David Burden, Siew Eng Choon, Kenneth Gordon, Lluis Puig, Arash Mostaghimi, Georgios Kokolakis, Na Hu, Patrick Hofmann, Christian Thoma, Milan Anadkat
Page s245
PDF
Effect of High-Dose Subcutaneous Spesolimab on Skin Manifestations: Results from the Pivotal Effisayil 2 Trial of Flare Prevention in Generalized Pustular Psoriasis
Bruce Strober, Matthias Augustin, Yayoi Tada, Amit Garg, Denis Jullien, Alice Gottlieb, Johann Gudjonsson, Na Hu, Patrick Hofmann, Christian Thoma, Angelo Marzano
Page s371
PDF
Spesolimab Use for Generalized Pustular Psoriasis Flare Prevention in Patients with Concomitant Plaque Psoriasis: Results from the Effisayil 2 Trial
Joseph Merola, Milan Anadkat, Neal Bhatia, Tina Bhutani, Laura Ferris, Arash Mostaghimi, .Jason Guercio, Christian Thoma, Ming Tang, Mark Lebwohl
Page s360
PDF
Spesolimab Rapidly Improves Quality of Life in Patients with Generalized Pustular Psoriasis, as per Dermatology Life Quality Index Scores: Data from the Effisayil 2 Trial
Alice Gottlieb, Bruce Strober, Georgios Kokolakis, Joseph Merola, Min Zheng, Richard Langley; Min Tang; Patrick Hofmann, Christian Thoma; Richard Warren
Page s409
PDF
Effect of Spesolimab on Achieving Sustained Disease Remission in Patients with Generalized Pustular Psoriasis: Results from the Effisayil 2 Study
Kenneth Gordon, Mark Lebwohl, Jonathan Barker, Tsen-Fang Tsai, Joseph Merola, Curdin Conrad, Min Zhang, Na Hu, Patrick Hofmann, Christian Thoma, Kilian Eyerich
Page s357
PDF
Effect of Spesolimab on Achieving Sustained Disease Remission in Patients with Generalized Pustular Psoriasis: Results from the Effisayil 2 Study
Kenneth Gordon, Curdin Conrad, Mark Lebwohl, Jonathan Barker, Tsen-Fang Tsai, Joseph Merola, Curdin Conrad, Min Zheng, Na Hu, Patrick Hofmann, Christian Thoma, Kilian Eyerich
Page s247
PDF
Measuring GPPGA, Pain, Symptom, and Quality of Life Index Scores in Untreated Generalized Pustular Psoriasis: Results from the Placebo Group of the Effisayil-2 Trial
Bruce Strober, Arash Mostaghimi, Milan Anadkat, Christian Thoma, Ming Tang, Jason Guercio, Mark Lebwohl
Page s361
PDF
Low Occurrence of Predefined Safety Events Across Six Randomized Clinical Trials of Spesolimab in Dermatologic Conditions
Kenneth Gordon, Kilian Eyerich, Milan Anadkat, Siew Eng Choon, Boni Elewski, Jonathan Barker, Arash Mostaghimi, Ming Tang, Thomas Haeufel, Christian Thoma, Diamant Thaci
Page s410
PDF
1 - 8 of 8 items
×
Modal Header